STANGA, SERENA

STANGA, SERENA  

DIPARTIMENTO DI FARMACOLOGIA SPERIMENTALE ED APPLICATA (attivo dal 01/01/2000 al 31/12/2010)  

Mostra records
Risultati 1 - 6 di 6 (tempo di esecuzione: 0.015 secondi).
Titolo Data di pubblicazione Autore(i) File
Deconstruction of Neurotrypsin Reveals a Multi-factorially Regulated Activity Affecting Myotube Formation and Neuronal Excitability 1-gen-2022 Canciani, Anselmo; Capitanio, Cristina; Stanga, Serena; Faravelli, Silvia; Scietti, Luigi; Mapelli, Lisa; Soda, Teresa; D'Angelo, Egidio; Kienlen-Campard, Pascal; Forneris, Federico
Homeodomain interacting protein kinase 2: a target for Alzheimer's beta amyloid leading to misfolded p53 and inappropriate cell survival. 1-gen-2010 Lanni, Cristina; Nardinocchi, L; Puca, R; Stanga, Serena; Uberti, D; Memo, M; Govoni, Stefano; D'Orazi, G; Racchi, Marco
Pharmacogenetics and pharmagenomics, trends in normal and pathological aging studies: focus on p53. 1-gen-2008 Lanni, Cristina; Racchi, Marco; Uberti, D; Mazzini, G; Stanga, Serena; Sinforiani, E; Memo, M; Govoni, Stefano
The expanding universe of neurotrophic factors: therapeutic potential in aging and age-associated disorders. 1-gen-2010 Lanni, Cristina; Stanga, Serena; Racchi, Marco; Govoni, Stefano
Unfolded p53 in blood as a predictive signature signature of the transition from mild cognitive impairment to Alzheimer's disease. 1-gen-2010 Lanni, Cristina; Racchi, Marco; Stanga, Serena; Mazzini, G; Ranzenigo, A; Polotti, R; Memo, M; Govoni, Stefano; Uberti, D.
Unfolded p53 in the pathogenesis of Alzheimer's disease: is HIPK2 the link? 1-gen-2010 Stanga, Serena; Lanni, Cristina; Govoni, Stefano; Uberti, D; D'Orazi, G; Racchi, Marco